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Abstract. 
 
In the neuroendocrine cell line, PC12, synap-
tic vesicles can be generated from endosomes by a sort-
ing and vesiculation process that requires the hetero-
tetrameric adaptor protein AP3 and a small molecular 
weight GTPase of the ADP ribosylation factor (ARF) 
family. We have now discovered a second pathway that 
sorts the synaptic vesicle-associated membrane protein 
(VAMP) into similarly sized vesicles. For this pathway 
the plasma membrane is the precursor rather than en-
dosomes. Both pathways require cytosol and ATP and 
are inhibited by GTP
 
g
 
S. The second pathway, however, 
uses AP2 instead of AP3 and is brefeldin A insensitive. 
The AP2-dependent pathway is inhibited by depletion 
of clathrin or by inhibitors of clathrin binding, whereas 
the AP3 pathway is not. The VAMP-containing, 
plasma membraneÐderived vesicles can be readily sepa-
rated on sucrose gradients from transferrin (Tf)-con-
taining vesicles generated by incubating Tf-labeled 
plasma membrane preparations at 37
 
8
 
C. Dynamin-
interacting proteins are required for the AP2-mediated 
vesiculation from the plasma membrane, but not from 
endosomes. Thus, VAMP is sorted into small vesicles 
by AP3 and ARF1 at endosomes and by AP2 and clath-
rin at the plasma membrane.
Key words: synaptic vesicles ¥ clathrin ¥ plasma mem-
brane ¥ PC12 cells ¥ VAMP
 
N
 
erve
 
 terminals contain synaptic vesicles of uni-
form diameter that release their neurotransmitter
content by exocytosis. After exocytosis, the vesi-
cle membrane is recycled from the plasma membrane to
form a vesicle, which quickly fills up with neurotransmit-
ter. The recycling and refilling processes are very efficient,
allowing the nerve terminal to maintain remarkably high
rates of neurotransmitter release. Some vesicle recycling
might be by a neuron-specific form of exocytosis referred
to as Òkiss-and-runÓ (Klingauf et al., 1998). Evidence that
a considerable fraction of the recycling process uses con-
ventional, clathrin-mediated endocytotic machinery comes
from genetics, morphology, and subcellular fractionation.
Mutations in the heterotetrameric adaptor complex, adap-
tor protein AP2
 
1
 
 (Gonzalez-Gaitan and Jackle, 1997), or
in the large GTPase, dynamin (van der Bliek et al., 1993;
Herskovits et al., 1993), block the reformation of vesicles.
Clathrin-coated vesicles are more abundant in rapidly
stimulated nerve terminals (Heuser and Reese, 1973).
Clathrin-coated vesicles isolated from nerve terminals are
enriched in synaptic vesicle membrane proteins (Maycox
et al., 1992). Although there is some ambiguity about
whether synaptic vesicles are formed from the plasma
membrane, the endosome, or both (for review see De
Camilli and Takei, 1996), there is little doubt that clathrin
and dynamin are involved.
Synaptic vesicle formation involves both vesiculation
and sorting of synaptic vesicle membrane proteins. It is a
favorable experimental system for the study of vesicula-
tion and sorting processes since the synaptic vesicle mem-
brane is simple and almost completely characterized. This
laboratory has developed an in vitro system that reconsti-
tutes the formation of neuroendocrine synaptic vesicle-
like microvesicles, here referred to more simply as synap-
tic vesicles (SVs), by incubating labeled membranes from
neuroendocrine PC12 cells in the presence of ATP and
brain cytosol (Desnos et al., 1995). The donor organelle
for this pathway is an endosome-like organelle (Lichten-
stein et al., 1998). To our surprise, depletion of clathrin,
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AP2, and dynamin from brain cytosol had no detectable
effect on SV biogenesis (Fandez et al., 1997; Horng, J.,
and R.B. Kelly, unpublished observations). Further analy-
sis revealed that the coat that is recruited to the donor
compartment in the presence of ATP and the small GTP-
ase ADP ribosylation factor ARF1, was the heterotet-
rameric adaptor, AP3 (Faundez et al., 1998). Mice that
lack one of the subunits of AP3 have neuronal abnormali-
ties but are viable (Kantheti et al., 1998). This suggests
that there is a pathway of SV biogenesis in addition to the
one that involves endosomes and AP3.
In vivo evidence has been presented by Huttner and col-
leagues (Schmidt et al., 1997) that plasma membrane can
be a direct precursor of SVs in PC12 cells. Using a vesicle-
associated membrane protein (VAMP) mutant that exhib-
ited increased targeting to SVs, N49A/VAMP (Fandez
et al., 1997), we set out to reconstitute vesicle budding
from plasma membranes in vitro. The results reported
here show that vesicles with the sedimentation properties
of SVs, which contain multiple SV marker proteins such as
synaptophysin and SV2, and which exclude the Tf receptor
(TfR), can also be generated from the plasma membrane
in vitro. This alternative pathway of SV biogenesis has few
similarities with the endosome-derived pathway since it
uses AP2, clathrin, and dynamin-binding proteins. It thus
appears as if VAMP-containing SVs that exclude TfR can
be formed in two different ways in PC12 cells. Comparing
two pathways in the same cell allows us to state with some
confidence that recruitment of clathrin or dynamin-related
proteins is not essential for the AP3-mediated pathway in
vitro, nor is ARF1 essential for the AP2-mediated pathway.
 
Materials and Methods
 
125
 
I and ECL reagents were obtained from Amersham Corp. (Arlington
Heights, IL). Iodogen came from Pierce Chemical Co. (Rockford, IL).
ATP, GTP
 
g
 
S, creatine phosphate, creatine kinase, and Sephadex G25
spin columns were purchased from Boehringer Mannheim Corp. (India-
napolis, IN). Brefeldin A was purchased from Epicentre Technologies
(Madison, WI). Percoll was obtained from Sigma Chemical Co. (St. Louis,
MO) and rat Tf was purchased from Jackson ImmunoResearch Laborato-
ries, Inc. (West Grove, PA). Cell culture media and reagents were ob-
tained from the University of California Cell Culture Facility (San Fran-
cisco, CA), with the exception of Geniticin (G418), which was obtained
from GIBCO BRL (Gaithersburg, MD). All the other reagent grade
chemicals were purchased either from Sigma, Fisher Scientific Co. (Fair-
lawn, NJ), or Calbiochem-Novabiochem Corp. (La Jolla, CA). Female
Sprague-Dawley rats were from Bantin and Kingman (Fremont, CA).
 
Cell Culture
 
PC12 cell lines were stably transfected to express rat VAMP, to which a T
antigen (TAg) epitope was attached at the COOH lumenal end (VAMP-
TAg). Unless stated otherwise, the VAMP was the mutant N49A form
(Grote et al., 1995). Cells were grown in DME H-21 media supplemented
with 10% horse serum, 5% FBS, 100 U/ml penicillin, and 100 
 
m
 
g/ml strep-
tomycin, and with 250 
 
m
 
g/ml G418. The cells were treated for 24 h before
the experiments with 6 mM sodium butyrate to induce the expression of
the N49A/VAMP-TAg construct.
 
Recombinant Proteins
 
GST control fusion protein was generated by expression of the plas-
mid pGEX-3X (Pharmacia, Piscataway, NJ). GST-Dyn-PRD was con-
structed as described in Roos and Kelly (1998). The preparation of con-
structs encoding the COOH-terminal appendage domains of the 
 
b
 
AP3,
GST-
 
b
 
3A (810Ð1094), GST-
 
b
 
3B (799Ð1081) and GST-
 
b
 
3A
 
mt
 
 (
 
b
 
3A with
amino acids 820Ð822 mutated to alanine) has been described elsewhere
(DellÕAngelica et al., 1997, 1998). Polyhistidine-tagged clathrin heavy
chain fragment (hub) was a gift of F. Brodsky (University of California,
San Francisco, CA). Expression of GST fusion proteins followed the rec-
ommendations of the manufacturer. Fusion proteins were bound to glu-
tathioneÐagarose (Sigma), eluted in glutathione elution buffer (20 mM
glutathione/50 mM Tris-HCl, pH 8.0/120 mM NaCl), concentrated in a
CentriPrep 10 concentrator (Amicon, Beverly, MA) and dialyzed against
intracellular buffer (38 mM potassium asparate, 20 mM potassium MOPS,
pH 7.2, 5 mM reduced glutathione, 5 mM sodium carbonate, 2.5 mM mag-
nesium sulfate). Fusion protein concentration was determined using the
BCA reagent system (Pierce Chemical Co.) and stored at 
 
2
 
20
 
8
 
C. Hub was
produced as described in Liu et al. (1995). In brief, hub-containing
BL21(DE3) bacteria (Novagen, Madison, WI) were induced with 0.8 mM
isopropyl-
 
b
 
-
 
d
 
-thiogalactopyranoside (IPTG) for 3 h at 30
 
8
 
C. Protein was
purified from bacterial lysates in binding buffer (50 mM Tris-HCl, pH 7.9,
0.5 M NaCl, 5 mM imidazole) by binding to a Ni
 
2
 
1
 
 affinity resin, eluted
with binding buffer plus 245 mM imidazole, and then dialyzed against in-
tracellular buffer.
 
Cell Labeling and Subcellular Fractionation
 
PC12 cells expressing the VAMP-TAg construct (N49A) were labeled
with 
 
125
 
I-KT3 mAb to the TAg epitope, following the methods of Desnos
et al. (1995). In brief, confluent 15-cm dishes of cells were washed at 4
 
8
 
C
with labeling buffer (PBS supplemented with 3% BSA, 0.3 mM CaCl
 
2
 
,
0.3 mM MgCl
 
2
 
, and 1 mg/ml glucose), labeled with 
 
125
 
I-KT3 (5Ð10 
 
m
 
g/ml)
in the same buffer at 4
 
8
 
C for 1 h, and then transferred to 15
 
8
 
C or retained
at 4
 
8
 
C for an additional 1 h.
The same conditions were used to label cells with 
 
125
 
I-Tf, except that
before the labeling procedure, cells were incubated for 1 h at 37
 
8
 
C in se-
rum-free medium (DME-H21) to deplete their stores of Tf. The concen-
tration of iron-loaded rat Tf in labeling buffer was 20 nM.
After labeling, the cells were extensively washed in the same buffer,
scraped, and then sedimented at 800 
 
g
 
 for 5 min. Cell pellets were gently
resuspended in intracellular buffer containing protease inhibitors.
Homogenizations were performed by eight passes through a ball bearing
homogenizer (cell cracker; European Molecular Biology Laboratory,
Heidelberg, Germany) with 12 
 
m
 
m clearance. A Percoll step gradient was
used to obtain membranes free of cytosol. The step gradients were formed
by 9 ml of 10% and 3 ml of 50% Percoll (100% Percoll is 1 vol of 10
 
3
 
 in-
tracellular buffer and 9 vol of Percoll with protease inhibitors). After col-
lecting the membranes at the 10Ð50% Percoll interface, a protein assay of
the membranes was performed using the Bio-Rad Protein Assay Dye Re-
agent (Bio-Rad Laboratories, Hercules, CA) using BSA as standard.
 
In Vitro Budding Assay
 
VAMP-TAg/N49A PC12 cells were labeled as described above. Aliquots
of 1 mg homogenate (or Percoll-washed membranes) were incubated for
30 min at 37
 
8
 
C or 4
 
8
 
C in the presence of an ATP-regenerating system
(1 mM ATP, 8 mM creatine phosphate, 5 mg/ml creatine kinase), and 1Ð4
mg/ml of rat brain cytosol prepared as described (Desnos et al., 1995). In
reactions containing peptides, mixtures were preincubated for 15 min at
4
 
8
 
C before warming up. The reactions were stopped by chilling to 4
 
8
 
C for
10 min before fractionation.
After the in vitro incubation a postnuclear supernatant was prepared
by sedimenting first at 1,000 
 
g
 
 for 5 min (S1) and then at 27,000 
 
g
 
 for 35
min (S2). Vesicles in the S2 (150Ð250 
 
m
 
l, 2Ð5 mg/ml) were quantified by
velocity sedimentation on 5Ð25% glycerol gradients prepared in intracel-
lular buffer (218,000 
 
g
 
 for 75 min at 4
 
8
 
C in a SW55 rotor; Beckman Instru-
ments, Inc., Palo Alto, CA). Fractions (16 or 17) were collected from the
bottom and counted on a gamma counter. About 1Ð2% of the plasma
membrane label was recovered in SV-containing fractions of the glycerol
gradient.
 
Immunoadsorption of SVs
 
SVs isolated by glycerol velocity gradient (fractions 8Ð10) were pooled
and aliquoted. Dynabeads M-450 (Dynal Inc., Great Neck, NY) preincu-
bated with mAbs against syntaxin (Sigma); synaptophysin (Boehringer
Mannheim Corp.); SV2 (Buckley and Kelly, 1985); synaptobrevin (69.1);
synaptogyrin (80.1, provided by R. Jahn, Yale University, New Haven,
CT); or, as a control, mouse 
 
g
 
-globulin (ICN Pharmaceuticals, Inc., Irvine,
CA) were added to each aliquot. After 16-h incubation at 4
 
8
 
C, the beads 
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were isolated, and then washed with PBS plus 1% BSA twice for 5 min.
Both isolated beads and the supernatant of each reaction were counted on
a gamma counter.
 
Immunodepletion of Clathrin and 
 
a
 
-Subunit of AP2
 
Clathrin heavy chains and AP2 complexes were quantitatively removed
from rat brain cytosol using the X22 mAb to clathrin heavy chain and AP6
mAb that binds 
 
a
 
-adaptin, respectively (Brodsky, 1985). In brief, 60 
 
m
 
g of
antibody were bound overnight to 40 
 
m
 
l of packed protein GÐSepharose
in 0.5 ml of intracellular buffer. Unbound Ig was removed by extensive
washing in intracellular buffer, and then the antibody-bound affinity ma-
trix was incubated with 0.8 mg of cytosol for 2 h at 4
 
8
 
C with gentle rocking.
The Sepharose beads were removed by centrifugation and the cytosol re-
covered for in vitro reactions. The beads were washed to remove cytosolic
proteins. Bead-bound and free cytosolic clathrin or 
 
a
 
-adaptin were deter-
mined by immunoblotting using an antiÐclathrin heavy chain antibody or
an antiÐ
 
a
 
-adaptin antibody (Transduction Laboratories, Lexington, KY).
Blots were performed using an enhanced chemiluminescence (Amersham
Corp.) system. The cytosol protein concentration before and after the de-
pletion remained constant.
 
Confocal Immunofluorescence Microscopy
 
Immunofluorescence procedures and confocal microscopy have been de-
tailed elsewhere (Bonzelius et al., 1994). In brief, N49A/PC12 cells were
plated in poly-
 
d
 
-lysineÐcoated Permanoxª slides (Nunc Inc., Naperville,
IL) 2 d before staining. Cells were loaded in vivo with KT3 antibodies (10
 
m
 
g/ml) in labeling buffer and washed as with labeling buffer with or with-
out 30 mM glycine, pH 2.4, as previously described (Grote and Kelly,
1996). Then cells were fixed in 4% PFA in PBS, permeabilized in 0.02%
saponin in PBS, 2% BSA, 1% fish skin gelatin, and then incubated with
affinity-purified fluorescent-labeled goat antiÐmouse IgG (Cappel Labo-
ratories, Malvern, PA). Observation and image acquisition were per-
formed in a Bio-Rad MRC600 confocal laser scanning microscope (Bio-
Rad Laboratories).
 
Results
 
Labeling the Plasma Membrane of N49A/PC12 Cells
 
To study vesicle formation from the plasma membrane, we
generated homogenates of PC12 cells in which only SV
proteins on the plasma membrane were labeled. The PC12
cell line used in the current study (N49A/PC12) was stably
transfected with a luminally tagged VAMP construct that
had a point mutation (N49A) in the cytoplasmic tail. This
VAMP derivative shows increased targeting to SVs com-
pared with wild type (Grote et al., 1995), and even more
specific targeting to SVs than the del61-70 mutation used
in a previous study (Desnos et al., 1995). To label the
plasma membrane, N49A/PC12 cells were incubated at
4
 
8
 
C with antibodies (KT3) against the lumenal epitope.
Immunofluorescent staining was detected around the cell
periphery with no detectable staining of any intracellular
structures (Fig. 1 
 
A
 
). The peripheral labeling could be
stripped away with an acid wash (Fig. 1 
 
B
 
), indicating that,
at 4
 
8
 
C, the antibodies only labeled epitopes exposed on
the cell surface. In a control experiment, when N49A-
transfected cells were labeled at 37
 
8
 
C for 40 min, the anti-
bodies were internalized and an intense, acid stripÐresis-
tant intracellular staining could be observed (Fig. 1, 
 
C
 
 and
 
D
 
). Restriction of label to the cell surface was confirmed
by biochemical subcellular fractionation experiments. In-
tact N49A cells were labeled at 4
 
8
 
C with iodinated KT3
followed by homogenization and fractionation on sucrose
density gradients. A peak of radioactivity was recovered at
38% sucrose, which represents labeled plasma membranes
(Clift-OÕGrady et al., 1998). Thus, incubating cells with an-
tibody at 4
 
8
 
C only labels the cell surface.
 
Vesicle Budding from the Plasma Membrane
 
To reconstitute in vitro vesicle budding from the plasma
membrane, we labeled intact N49A cells with iodinated KT3
at 4
 
8
 
C for 2 h. After washing away the unbound antibody,
the cells were homogenized and the homogenate incubated
at 37
 
8
 
C in the presence of rat brain cytosol and an ATP-
regenerating system. After the incubation, the reaction
mix was centrifuged to remove large membranes and the
supernatant was analyzed by glycerol velocity sedimenta-
tion. As shown in Fig. 2 (
 
circles
 
), we observed radioactivity
in the SV-containing fractions (8Ð12) of the glycerol gradi-
Figure 1. The plasma membrane
of N49A/PC12 cells is labeled
with KT3 mAb at 48C. N49A/
PC12 cells were incubated in the
presence of KT3 mAb (10 mg/
ml) for 15 min at 48C. Cells were
then warmed up to 378C for 40
min (C and D) or kept at 48C (A
and B). In B and D, cells were
treated with an acid wash (see
Materials and Methods) at 48C
before fixation. The immunoflu-
orescence was processed as de-
scribed. After labeling at 48C,
the label can be removed by an
acid wash, but not after warming
to 378C. Bars, 10 mM. 
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ent, as well as in free antibody at the top of the gradient
(14 and above). SV generated by labeling N49A cells at
15
 
8
 
C followed by an in vitro reaction at 37
 
8
 
C (Desnos et
al., 1995) also migrate to the same glycerol fractions (Fig.
2, 
 
diamonds
 
). The amount of radioactivity recovered in
the SV peak was always about five times less when labeled
plasma membrane was used, compared with labeled endo-
somes. The relatively weak signal was probably due to the
limited amount of VAMP on the cell surface compared
with the amount internalized at 15
 
8
 
C. The small size of the
signal, the shorter incubation time, and the use of a less
advantageous mutant VAMP (del61-70) may explain why
no budding from plasma membranes was observed in ear-
lier experiments (Desnos et al., 1995). Nonetheless, when
expressed as recovery of membrane-bound radioactivity in
SVs, the plasma membrane and the endosomal assays
have comparable efficiency.
 
Characterization of the Budding Reaction
 
In vitro vesicle budding is increased in efficiency by the
use of cytosol. As shown in Fig. 3 
 
A
 
, the amount of vesicles
generated in the budding reaction depended on the con-
centration of rat brain cytosol, suggesting that cytosolic
factors are required for vesicle formation from the plasma
membrane. A small vesicle peak was often observed in
control reactions with no added rat brain cytosol. Since
this background reaction is seen with washed membranes
it may be due to coating proteins that remain bound to the
plasma membrane after homogenization. As indicated by
Western blot, clathrin and 
 
a
 
-adaptin can be detected on
the washed membranes (not shown). Immunofluorescence
also supports the association of dynamin (Estes et al.,
1996; Roos and Kelly, 1998) and AP2 (Gonzales-Gaitan
Figure 2. In vitro budding
from cell homogenate labeled
at 48C or 158C. Cell homoge-
nate (1 mg) was prepared
from N49A/PC12 cells la-
beled with 125I-KT3 at 48C for
2 h. The homogenate was
then incubated with rat brain
cytosol (1.5 mg/ml) and ATP
at 378C (closed circles) or 48C
(open circles) for 30 min fol-
lowed by centrifugation of
a high speed supernatant
(S2) on a 5Ð25% glycerol ve-
locity gradient. A significant
amount of 125I-KT3 was re-
covered in fractions 8Ð12 (closed circles), cosedimenting with the
SVs (closed diamonds) generated by an in vitro reaction using
homogenate from 158C-labeled N49A PC12 cells (Desnos et al.,
1995). No labeled KT3 was recovered in the SV peak when the in
vitro reactions were performed at 48C (158C cell labeling, open
diamonds; 48C cell labeling, open circles). The label at the top
(right-hand side) of the gradients is free antibody.
Figure 3. Characterization
of the in vitro budding reac-
tion from 48C-labeled mem-
branes. (A) Effect of rat
brain cytosol concentration.
Standard reactions were per-
formed using Percoll-washed
membranes with different
concentrations of rat brain
cytosol: 0 mg/ml (open cir-
cles), 0.5 mg/ml (closed dia-
monds), 1 mg/ml (open dia-
monds), and 2 mg/ml (closed
circles). The high speed su-
pernatants (S2) of each reac-
tion were centrifuged on a
5Ð25% glycerol velocity gra-
dient. The radioactivity of
each fraction was plotted
against fraction numbers. (B)
Kinetics of the in vitro bud-
ding reaction. The amount
of  125I-KT3 recovered in the SV peak (pool of fractions 8Ð12) after a complete
budding reaction was measured as a function of time. (C) Nucleotide dependence
of the budding reactions. Standard in vitro budding reactions were carried out
under normal budding conditions (Percoll-washed membranes, rat brain cytosol,
and ATP at 378C), or with 20 mM GTPgS, or in the absence of the ATP regenera-
tion system. (Note that nucleotides in rat brain cytosol were removed by dialysis
against intracellular buffer.) Vesicle production (radioactivity in fractions 8Ð12)
was normalized as a percentage of the yield obtained under normal conditions
(Control). Reactions at 48C were subtracted as backgrounds. Error bars represent
the range of the results for two independent experiments. The cytosol concentra-
tion in all experiments was 1.5 mg/ml.Shi et al. Two Synaptic Vesicle Pathways 951
and Jackle, 1997) with the plasma membrane at endocy-
totic Òhot spots.Ó
A time course of vesicle budding from the in vitro re-
constitution systems indicated that detectable vesicle pro-
duction starts within 10 min of incubation and reaches a
plateau in z40 min (Fig. 3 B), not significantly different
from kinetics of the in vitro SV budding from endosomes
(Desnos et al., 1995). Vesicle formation was reduced when
the ATP-regenerating system was omitted in the reaction
mix (Fig. 3 C). The presence of GTPgS in the reconsti-
tuted system greatly inhibited the generation of SVs, in
line with the possible involvement of dynamin or other
GTPases in endocytosis from the plasma membrane (Nu-
offer and Balch, 1994; Takei et al., 1995, 1996; Carter et al.,
1993).
Newly Formed SVs Contain Multiple SV Proteins and 
Exclude Tf
Although neuroendocrine cells such as PC12 are not syn-
apse-forming neurons, they have organelles that resemble
SVs. Three criteria that are conventionally used to de-
scribe the SVs in PC12 cells are their homogeneous size,
the presence of a full array of SV proteins, and the absence
of other recycling plasma membrane proteins such as the
TfR. To determine if SV markers other than VAMP are
present on the small vesicles, M-450 Dynabeads (sheep
antiÐmouse IgG) coated with mAbs against SV proteins
synaptophysin, synaptogyrin, or SV2 were used to immu-
noadsorb the vesicle fractions. As shown in Fig. 4 A, each
of these antibodies adsorbed most of the radioactivity as-
sociated with the vesicle fractions. As expected, an almost
complete adsorption was also achieved by an antibody
against VAMP (synaptobrevin; Fig 4 A). However, anti-
bodies against a t-SNARE protein, syntaxin, did not
bind  vesicles above the level of controls containing mouse
g-globulin confirming earlier observations (Salem et al.,
1998). This result shows that the small vesicles formed
from the plasma membrane, as expected for SVs, contain a
spectrum of SV markers.
To determine if the VAMP-containing vesicles that
formed from the plasma membrane are devoid of TfR,
PC12 cells were labeled at 48C with 125I-Tf, homogenized,
and then incubated in vitro with brain cytosol and ATP.
No radioactivity was recovered in the SV peak region after
glycerol velocity sedimentation of the reaction products
(data not shown).
The absence of labeled Tf in SV fractions could be be-
cause the levels were too low to detect. To determine if
other Tf-containing vesicles were made, we analyzed the
reaction products differently using a sucrose velocity gra-
dient protocol that resolves SVs from other membrane
populations (Lichtenstein et al., 1998). Intact N49A/PC12
cells were labeled with iodinated Tf at 48C as before,
washed, homogenized, and then the homogenate was incu-
bated at 378C under standard conditions. After the reac-
tion, the plasma membrane was removed from the reac-
tion mix by a lower speed, 5,000 g min centrifugation to
allow the analysis of membrane vesicles larger than SVs.
The supernatant of the reaction mixture was analyzed on a
10Ð45% sucrose density gradient. Using this new protocol,
Tf-containing vesicles were recovered at 28% 6 0.5 su-
crose (Fig. 4 B, closed circles), a density different from that
at which the KT3-containing vesicles were recovered
(23%  6 1.5 sucrose), as shown in Fig. 4 C (closed dia-
monds). Our results indicate that VAMP-containing SVs,
from which the TfR has been segregated, can bud from the
plasma membrane, suggesting that protein sorting may be
occurring directly at the plasma membrane.
Small amounts of label, especially in Tf, are recovered
between 35% and 40% sucrose in the 5,000 g min superna-
tants from cells labeled at 48C (Fig. 4 B). The label is pre-
sumably due to small fragments of plasma membrane that
are not pelleted. They disappeared during the in vitro in-
Figure 4. (A) Immunoadsorp-
tion of SVs derived from the
plasma membrane. Aliquots of
SVs were incubated with M-450
Dynabeads (3 mg per reac-
tion) coated with anti-VAMP
(synaptobrevin), anti-synap-
tophysin (SY-38), anti-synap-
togyrin (p29), anti-SV2, or
anti-syntaxin antibodies. Mouse
g-globulin was used to deter-
mine non-specific binding.
After extensive wash, the ra-
dioactivity associated with
the beads was plotted as a
percentage of total radioac-
tivity for each reaction. (B
and C) TfRs are sorted from
SVs from plasma membrane.
N49A/PC12 cells were labeled
with 125I-Tf (0.2 mg/ml; B) or
125I-KT3 (10 mg/ml; C) at 48C
for 2 h. The cell homogenate
was incubated with rat brain cytosol and ATP at 378C (closed
symbols) or 48C (open symbols). A low speed (5,000 g min) su-
pernatant was made from each reaction and centrifuged on a 10Ð
45% sucrose velocity gradient. Radioactivity of each gradient
fraction was plotted against its sucrose concentration. Radioac-
tivity from 125I-KT3 was recovered at 23% (1.5 sucrose; closed di-
amonds), similar to the SVs generated from endosomes (Lichten-
stein et al., 1998). However, 125I-TfÐlabeled membranes were
recovered at 28% (0.5 sucrose; closed circles), well separated
from the SVs.The Journal of Cell Biology, Volume 143, 1998 952
cubation, implying that they are potential precursors of
the Tf-labeled vesicles at 28% sucrose. The nature of this
putative precursor is not yet known.
SV Formation from the Plasma Membrane Requires 
AP2 and Clathrin But Not ARF1
Although the plasma membrane was the only labeled pre-
cursor added to the reaction mix it was possible that the
plasma membrane was generating endosomes from which
SVs were budding by an AP3 and ARF-dependent mecha-
nism. To examine this possibility we took advantage of the
sensitivity of the endosomal budding reaction to a fungal
metabolite, brefeldin A (BFA).
ARF1, a small GTP-binding protein, is required for SV
biogenesis from endosomes (Fandez et al., 1997). Its
function is to recruit the AP3 adaptor complex as a coat to
mediate vesicle budding (Fandez et al., 1998). A hall-
mark of ARF1-mediated processes is their sensitivity to
BFA, which inhibits GDPÐGTP exchange activity of ARF1
(Donaldson et al., 1992). As shown in Fig. 5 (closed cir-
cles), SV biogenesis from endosomes was inhibited by
BFA in a dose-dependent manner as described previously
(Fandez et al., 1997). However, the vesicle production
from the plasma membranes was not inhibited in the pres-
ence of BFA #500 mg/ml. The difference in BFA sensitiv-
ity implies that coat recruitment to allow vesicle budding
from the plasma membrane does not require a cytoplasmic
ARF1. These observations are consistent with the previ-
ous reports showing that BFA inhibits vesicle formation
from the TGN, but not from the cell surface (Robinson
and Kreis, 1992).
We were unable to obtain any evidence that clathrin
(Faundez et al., 1997) or AP2 (Horng, J.-T., and R.B. Kelly,
unpublished) were required for SV formation from endo-
somes. In contrast, SV formation from the plasma mem-
brane needs clathrin and AP2. When the cell-free reconsti-
tution system was supplied with rat brain cytosol depleted
of clathrin heavy chain or AP2 (a-adaptin), the vesicle pro-
duction was reduced (Fig. 6 A). The extent of depletion
was confirmed by Western blotting of rat brain cytosol
with clathrin and a-adaptinÐspecific antibodies (Fig. 6 B).
The clathrin involvement was further tested using a bac-
terially expressed clathrin heavy chain fragment, often
called the hub domain. The clathrin hub fragment is the
minimal trimerization domain that can self-assemble into
clathrin triskelions in vitro (Liu et al., 1995). It interferes
with endogenous clathrin function by blocking clathrin
polymerization into polyhedral vesicle coats (Liu et al.,
1998). An inhibitory effect on vesicle biogenesis was ob-
served upon the addition of the hub fragment (Fig. 6 A).
These results suggest that the clathrin/AP2-coating com-
plex is necessary to form KT3-containing vesicles from the
plasma membrane.
In these depletion studies, inhibition of SV formation
was never complete. This was expected since SV forma-
tion was only stimulated about twofold by the addition of
cytosol (Fig. 2). As discussed above, membrane-associated
protein machinery may also contribute to the budding ac-
tivity. To confirm that the inhibition was indeed due to
clathrin and AP2 depletion, coat proteins were isolated
from brain-coated vesicles by conventional procedures
(Manfredi and Bazari, 1987) and added back to the reac-
tion mix. When 80 mg/ml purified clathrin was added back
to clathrin-depleted cytosol, the budding activity recov-
ered to 87% of that before clathrin depletion. Similarly,
100 mg/ml AP2 restored the activity to 94%.
Clathrin Is Needed for AP2, But Not AP3-mediated SV 
Formation In Vitro
Originally it was reported (Simpson et al., 1996) that clath-
rin did not codistribute with AP3 by immunofluorescence.
This was consistent with normal AP3-mediated sorting in
yeast cells lacking clathrin (Vowels and Payne, 1998) and
our own data from in vitro reconstitution showing clathrin
independence (Faundez et al., 1998). However, the COOH-
terminal appendage domain of the b3 subunit of AP3
binds clathrin, and AP3 and clathrin can be colocalized
on endosomes and TGN by immunoelectron microscopy
(DellÕAngelica et al., 1998).
Additional clathrin would not be needed in our in vitro
assay if there were already sufficient clathrin on the donor
membranes to generate budding. If that clathrin were
recruited to the COOH-terminal appendage domains of
AP3, then inhibition of budding might be seen in the pres-
ence of excess appendage domain. Incubating labeled en-
dosomes with excess appendage domain, however, gave
no inhibition of SV formation (Fig. 7 ES).
The absence of inhibition could be attributed to failure
to achieve inhibitory concentrations of appendage domain,
or the absence of clathrin recruitment from a membrane-
bound pool. The first explanation is less likely because the
AP3 appendage domains at the same concentration (150
mM) inhibited SV production from labeled plasma mem-
branes by z70% (Fig. 7 PM). With 75 mM appendage do-
main, the inhibition was 40% and with 38 mM, the inhibi-
tion was not significant. A mutant, GST-b3Amt, in which
residues DLD (820Ð822 of GST-b3A) are mutated to
three alanine residues, has no clathrin binding activity in
vitro (DellÕAngelica et al., 1998), and does not show an in-
hibitory effect on SV formation. The appendage domain
Figure 5. BFA inhibits in vitro SV formation from endosomes
but not from the plasma membrane. Cell homogenates from
N49A/PC12 cells labeled with 125I-KT3 at either 48C for 2 h (open
circles) or 158C for 40 min (closed circles) were incubated with rat
brain cytosol (1.5 mg/ml), ATP and the indicated amount of BFA
at 48C for 15 min before warming to 378C for 30 min. The amount
of SV production (radioactivity of fractions 8Ð12) was expressed
as a percentage of the yield obtained from reactions to which no
BFA was added.Shi et al. Two Synaptic Vesicle Pathways 953
of AP2 also inhibited (data not shown). These results are
consistent with the evidence that the b3 appendage do-
main binds clathrin as efficiently as the b2 appendage do-
main of AP2 and so might inhibit AP2-mediated recruit-
ment (DellÕAngelica et al., 1998).
The data on appendage inhibition are consistent with the
other data on clathrin dependence of the AP2 pathway. A
concern, however, with the use of appendage domains as
inhibitors is the high concentration needed (150 mM) to
obtain significant inhibition. Earlier experiments using the
AP2 appendage domains reported a very low affinity be-
tween appendage and clathrin (Shih et al., 1995) consistent
with our findings. The low affinity might not be real but
might reflect inefficient folding of the recombinant pro-
teins. It is encouraging that inhibition is not seen with mu-
tant appendages that do not have binding activity (Fig. 7).
To resolve definitively whether clathrin is involved in
AP3-mediated budding, high affinity inhibitors of clathrin-
mediated vesiculation are clearly needed.
The GTPase dynamin has been implicated in endocyto-
sis from the plasma membrane (van der Bliek et al., 1993;
Vallee and Okamoto, 1995; De Camilli and Takei, 1996).
To explore how dynamin might function in SV formation,
a fusion of GST to the proline-rich domain (PRD) of dy-
namin (GST-Dyn-PRD) was made and used to screen for
brain-specific proteins that bound to it (Roos and Kelly,
1998). Four major PRD-binding proteins were found in
brain extracts. To determine if dynamin or SH3-containing
proteins that bind to the Dyn-PRD were involved in SV
biogenesis from PC12 membranes, in vitro budding reac-
tions were incubated with either GST (control) or GST-
Dyn-PRD fusion proteins. The GST-Dyn-PRD protein
inhibited vesicle formation from plasma membranes by
.50%, but had no effect on budding from endosomes
(Fig. 8). We conclude that the proteins that bind dynamin
PRDs are likely to be involved in the AP2-mediated path-
way of vesicle biogenesis, but not the endosomal, AP3-
mediated pathway.
Discussion
We have reconstituted the biogenesis of SVs from the
plasma membrane of PC12 cells in vitro. Unlike the bio-
genesis of SVs from PC12 endosomes, the formation of
plasma membraneÐderived SVs requires AP2 and clathrin,
Figure 6. SVs generated from the plasma mem-
brane require clathrin and AP2. (A) Standard
in vitro budding reactions from 48C-labeled,
Percoll-washed N49A/PC12 membranes were
performed with clathrin-deficient cytosol,
with a-adaptin (AP2)-deficient cytosol, or
with normal cytosol containing 3 mg/ml clath-
rin hub fragment. SV production for each re-
action was expressed as the percentage of
that from control reactions (with only rat
brain cytosol). The variability in results with
the hub fragment may be due to difficulties in
keeping it in solution. (B) Antibodies specific
for clathrin heavy chain (X22) or a-adaptin
(AP6), respectively, were used to deplete
clathrin and AP2 adapter complex from rat
brain cytosol. After depletion, 200 mg of rat
brain cytosol (supernatant) and immunoprecipitated product (pellet) were fractionated by SDS-PAGE followed by Western blotting
with an anti-clathrin heavy chain antibody and an antiÐa-adaptin antibody. The remaining clathrin and a-adaptin in the cytosol were
plotted as a percentage of total clathrin and a-adaptin before depletion.
Figure 7. The putative appendage domain of b3 subunits of AP3
complex inhibits SV production from plasma membrane but not
that from endosome. Standard in vitro budding reactions were
performed with 48C-labeled (PM) or 158C-labeled (ES), Percoll-
washed N49A/PC12 membranes in the presence or absence of
150 mM GST fusion proteins bearing appendage domain of b3A,
b3B, or b3Amt. The amount of SV production was normalized to
the control reaction incubated with added 150 mM GST.
Figure 8. GST-Dyn-PRD in-
hibits SV formation from the
plasma membrane but not
that from endosomes. Stan-
dard in vitro budding reac-
tions with Percoll-washed
N49A/PC12 cell membranes
from cells labeled at 48C
(plasma membrane) or 158C
(endosome) were performed
with 300 mg/ml of GST-Dyn-
PRD or 800 mg/ml GST con-
trol protein. SV production
(fractions 8Ð12) with added
GST-Dyn-PRD was normalized as a percentage of that with GST
control proteins. PM, plasma membrane; ES, endosome.The Journal of Cell Biology, Volume 143, 1998 954
but not GTP hydrolysis by ARF1. This mode of small vesi-
cle biogenesis could be a model for the dominant pathway
of SV biogenesis in neurons, which is likely to involve AP2
and clathrin on the basis of genetic, morphological, and
cell fractionation evidence.
The presence of two distinct biosynthetic pathways in
the same cell type throws into sharper relief the differ-
ences between the AP2- and AP3-mediated pathways.
Most strikingly, AP2-mediated budding requires clathrin
recruitment under conditions that AP3 does not. The abil-
ity of clathrin triskelions to form pentagons and hexagons
has often led to the speculation, occasionally challenged
(Kirchhausen et al., 1997), that the function of clathrin is
to impart curvature to vesicles budding from a donor
membrane. If the AP3 adaptor in the absence of clathrin
can form vesicle-sized structures in vitro, then the recruit-
ment of clathrin is not essential for imparting curvature.
An alternative explanation is that clathrin recruitment is
not necessary because endosomes already have a large
pool of clathrin bound to the membranes. For this expla-
nation to be plausible, clathrin recruitment from the mem-
brane pool cannot be sensitive to the AP3 appendage do-
mains. Efforts to make the endosomal budding system
dependent on clathrin by stripping the endosome precur-
sors with high salt or Tris washes have not succeeded
(Horng, J.-T., and R.B. Kelly, unpublished).
Conversely, the AP3-dependent endosomal pathway,
but not the AP2-dependent plasma membrane one, re-
quires the addition of ARF1 in a GTP-bound form. Given
the involvement of small GTPases of the ARF family in
ER, Golgi, and endosomal budding events it is surprising
that recruitment of coat by the plasma membrane should
be different. One possible explanation is that the AP2 re-
cruitment mechanism is firmly bound to the plasma mem-
brane. ARF6, for example, is firmly associated with the
plasma membrane and is insensitive to BFA (DÕSouza-
Schorey et al., 1995; Peters et al., 1995).
The discovery of a second potential pathway of SV bio-
genesis helps us reconcile the findings of Schmidt et al.
(1997) with our own (Desnos et al., 1995; Faundez et al.,
1997, 1998). By following the internalization of biotiny-
lated synaptophysin, Schmidt et al. (1997) could show that
SVs were generated from a plasma membrane precursor,
not an endosomal one as we had proposed. It is very likely
that the experimental conditions chosen by Schmidt et al.
(1997) favored the discovery of the plasma membraneÐ
derived pathway, whereas ours favored the discovery of
the endosomal pathway. Using our techniques for moni-
toring vesicle formation conditions, almost all sSV biogen-
esis in vivo is sensitive to BFA and so occurs by the AP3
pathway.
Our earlier work had shown that PC12 endosomes con-
taining TfRs were precursors of SVs (Lichtenstein et al.,
1998). The original goal of the present paper was to ex-
plore the formation of the endosomal precursor from
plasma membranes. To our surprise we found that vesicles
were formed from plasma membrane in vitro that were re-
markably similar in size to SVs. To determine if these
small vesicles were endosomal precursors we did the type
of double-labeling experiments shown in Fig. 4, B and C.
The result was clearcut: the small vesicles do not contain
Tf. If the small vesicles were endosomal precursors that
subsequently fuse with TfR-containing endosomes, sorting
at the plasma membrane would be a futile process. A more
likely possibility is that VAMP gets to endosomes by an al-
ternative route. One possibility is the vesicles at 28% su-
crose (Fig 4, B and C), which appear to contain both Tf
and VAMP.
The absence of detectable Tf in the plasma membraneÐ
derived microvesicles is also consistent with the observa-
tions of Schmidt et al. (1997). The simplest explanation of
our data and those of Schmidt et al. (1997) is that there are
two separate pathways of internalization from the plasma
membrane, one that carries both SV proteins and carriers
such as the TfR and another that is exclusive for SV pro-
teins. A specialized internalization pathway for SV pro-
teins was first suggested by De Camilli and coworkers to
explain the differences between the endosomes in the ax-
ons and the cell bodies of neurons (Mundigl et al., 1993),
an observation confirmed later in PC12 cells (Bonzelius et al.,
1994). Recently evidence that more than one internaliza-
tion pathway exists has also been obtained by comparing
the GLUT4 glucose transporter with the TfR, after inter-
nalization at 158C (Wei et al., 1998). A clathrin-indepen-
dent pathway of internalization has been known for some
time (Sandvig and van Deurs, 1991; Lamaze and Schmid,
1995), but the pathway taken by VAMP-TAg described
here is both clathrin and dynamin dependent. If there are
two independent pathways of clathrin-mediated internal-
ization from the plasma membrane, some mechanisms
must exist to segregate their cargo proteins selectively.
It is not clear why PC12 cells should have two pathways
for making SV-like organelles. One possibility is that the
two classes of vesicle have different protein compositions.
Recent evidence suggests that the AP3-mediated pathway
in brain is tightly linked to the formation of a subclass of
SVs that contain one of the zinc transporters, ZnT3 (Kan-
theti et al., 1998). Another possibility is that the two path-
ways are used at different levels of synaptic activity. A
third is that neurons of a certain class, for example with
more of a neuroendocrine function, or with large nerve
terminals, or with extensive endocytosis of neurotropin re-
ceptors, use the AP3-mediated pathway. Fortunately the
tools are now available to distinguish these possibilities.
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